|
||||||||||
|
||||||||||
|
||||||||||
| |
|||
 |
|
|
|
|
||||||||||
|
||||||||||
|
||||||||||
| |
|||
|
|
|
|
| |||||||||
 |
|
| « Previous Thread | Next Thread » | Thread Tools | Search this Thread | Display Modes |
 Dev Articles Community Forums Sponsor: |
| #1  February 28th, 2005, 02:00 PM | |||
| |||
| Patient Dies: Biogen, Elan Halt MS Drug (Reuters) Reuters - Biogen Idec and Elan Corp. Plc on Monday suspended sales of their much-heralded new multiple sclerosis drug Tysabri after a patient died from a rare and often fatal infection of the central nervous system. View the Entire Article
|
|
| Viewing: Dev Articles Community Forums > Latest News Updated Hourly > Business News > Patient Dies: Biogen, Elan Halt MS Drug (Reuters) |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
| |
 | |
Del.icio.us
Digg
Google
Spurl
Blink
Furl
Simpy
Y! MyWeb
Linear Mode
